Available Positions for Postdoctoral Fellows
At NYU School of Medicine, we frequently post new opportunities for postdoctoral fellows to join our team of world-class biomedical investigators.
If you are interested in applying for an available position, please contact the principal investigator directly using the contact information included with the position listing. You might find additional postdoc opportunities by searching the NYU School of Medicine website for a researcher or department that interests you. There may be additional research opportunities available.
NYU School of Medicine researchers who have an available postdoctoral position they would like to add to this list can submit the new postdoctoral position submission form.
Current postdocs nearing the end of their appointment can log into the postdoc community using their Kerberos ID to browse a list of job openings. Faculty and administrators from outside institutions who wish to add a job opening to this list can do so by submitting a career opportunity form.
Current Postdoctoral Openings
NYU School of Medicine is an equal opportunity employer committed to fostering diversity for postdoctoral fellows in the workplace. The following positions offer competitive salaries, excellent benefits, and eligibility for student housing.
Genome Editing to Treat Cardiac Diseases—April 11, 2017
A postdoctoral position is available immediately in the laboratory of Chengzu Long, PhD, at NYU School of Medicine’s Leon H. Charney Division of Cardiology. Our projects focus on advancing the novel genome editing technology to model and treat cardiac and neuromuscular diseases (Long et al., JAMA Neurology. 2016).
The recent advance in novel precision genome editing technologies and human pluripotent stem cell biology are revolutionizing our approach to studying disease pathology and developing potential therapeutics. Using clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) genome editing, we successfully prevented muscular dystrophy in a mouse model (Long et al., Science. 2014; Long et al., Science. 2016). Recently, we began optimizing genome-editing strategies on the culprit genes in patients’ cardiomyocytes and in animal models (Zhang et al. Science Advances. 2017).
The ideal candidate will hold a PhD and/or an MD in biological sciences or biomedical-related fields. Candidates with expertise in molecular and cellular biology, genome editing, and stem cell biology are particularly encouraged to apply.
To apply or to obtain more information about the position, please contact Dr. Long at email@example.com. Applicants should include a CV, brief statement of research background, and the names of three references.
Pediatric Glioma Metabolism—March 29, 2017
A postdoctoral position is available in the laboratory of Richard L. Possemato, PhD, to participate in original biomedical research using metabolomics, DNA methylation profiling, high-throughput screening techniques, and cell- and animal-based models. Work independently in collaboration with Dr. Possemato and Matija Snuderl, MD, principal investigators in the pediatric glioma metabolism program at NYU School of Medicine.
Our lab is part of the vibrant tumor metabolism research community at NYU Langone’s brain tumor program and the Laura and Isaac Perlmutter Cancer Center. Postdocs attend international conferences and engage with scientific leaders in the field. Examples of previous work from our lab include the Nature publications “Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides” and “Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.”
The optimal postdoctoral researcher is enthusiastic and highly motivated to pursue a career in academic research, has recently obtained a PhD, and has a record of publication in high-quality scientific journals. Interested candidates should contact Dr. Possemato at firstname.lastname@example.org with their CV and any questions about the research, the lab, and NYU Langone.
Role of lncRNAs and Epigenetics in Breast Cancer—March 6, 2017
A multidisciplinary team of molecular biologists, cell biologists, biochemists, and clinicians studying the role of lncRNAs and epigenetic modifications in breast cancer is seeking a postdoctoral research associate. We have identified a number of interesting new noncoding RNAs that are misregulated in breast cancer and are attempting to analyze their role in growth control and breast cancer progression.
The successful candidate will pursue molecular biology and cell biology approaches to the analysis of lncRNAs in breast cancer. He or she will work in a joint computational and experimental environment with excellent resources for experimental validation of hypotheses generated by genomic analysis. Candidates must have a PhD in molecular biology, biochemistry, or a related field and a strong interest in gene expression and/or growth control. The laboratory is located in the heart of midtown Manhattan.
Bone Regeneration and Stem Cell Biology—March 6, 2017
The Leucht Lab in the Departments of Orthopaedic Surgery and Cell Biology at NYU School of Medicine has an immediate opening for a postdoctoral scientist. Our laboratory investigates the molecular mechanisms of adult fracture healing and bone regeneration. This position is for a highly motivated individual with considerable experience in cell biology and/or bone biology. Experience in animal models of human diseases is desirable but not required.
The successful applicant will work on a large project aimed at understanding the role of genetic and epigenetic regulators of embryonic patterning and skeletal development as they relate to adult bone repair.
Applicants should possess a PhD and/or MD in molecular biology, cell biology, or biochemistry and a strong publication record. Interested individuals should send a CV and the names and phone numbers of three people who could provide letters of reference by email to Philipp Leucht, MD, PhD, at email@example.com.
Inflammatory Mechanisms Involved in Aortic Aneurysm Formation in Mouse Models and Potential Application in Translational Medicine—February 6, 2017
A postdoctoral scientist position is available in the laboratory of Bhama Ramkhelawon, PhD, to study the inflammatory mechanisms involved in the development of abdominal aortic aneurysm. Abdominal aortic aneurysms are characterized by a focal dilatation of the aortic diameter located in the infrarenal section of the aorta. They account for approximately 15,000 deaths annually and are responsible for 1 to 2 percent of all deaths in men over age 65, making it the 13th deadliest disease in the United States.
The innate immune system, macrophages in particular, plays a critical role in degrading the extracellular matrix, major components of the aortic vessel wall. Studies are underway in Dr. Ramkhelawon’s laboratory to understand the role of macrophages and the mechanisms involved in their recruitment and proliferation in abdominal aortic aneurysms. We use cutting-edge resources including live Doppler imaging, RNA sequencing, and laser capture microdissection for our studies using both genetically modified mice models and human samples.
Candidates demonstrating the ability to be creative and highly motivated, to work independently and multitask, and possess a strong background in cardiovascular research are preferred. It is mandatory that candidates routinely use FACS/FlowJo software and are familiar with mice work. Applicants with additional skills in RNA sequencing analysis, tissue culture, cell biology, and general molecular biology and biochemical techniques are encouraged.
Applicants should hold a PhD and have strong laboratory and analytical skills. Significant experience in cardiovascular and immunology research is required. Good communication, organizational skills, excellent team spirit, and a strong work ethic are a must. The ability to work independently and to provide innovative solutions to complex problems is important.
This position is an exciting opportunity and will provide an excellent training environment to work in a dynamic, highly enriched and interactive laboratory within the vibrant research community at NYU School of Medicine.
To apply or to obtain more information about the position , email Jordyn Feinstein at firstname.lastname@example.org. Interested applicants should submit a cover letter indicating current and future research interests and expected availability date; a CV; a description of past research experience and accomplishments; and the names of three references.
Signaling Events Related to Inhibitory Receptors in T Cells—February 3, 2017
A postdoctoral position is available in NYU School of Medicine’s Department of Medicine and NYU Langone’s Laura and Isaac Perlmutter Cancer Center. The ideal candidate will work in a collaborative manner under a joint mentorship of Adam Mor, MD, PhD, in the Department of Medicine and Mark Philips, MD, at Perlmutter Cancer Center. The goal of our laboratory is to improve the treatment and outcome of patients with cancers. Our approach to do that is by studying the lymphocyte, the leading cell involved in host response against malignancies. More specifically, we are interested in exploring signaling events related to inhibitory receptors in T cells. The successful candidate will investigate novel and targetable co-receptors signaling pathways in T lymphocytes. He or she will join a dedicated and hardworking team determined to reach results that will change the way we treat malignancies.
Candidates must have a PhD or MD with a solid background in one or more of the following fields: immunology, cell biology, proteomics (mass spectrometry and data analysis), and animal models of solid tumors. Candidates should demonstrate an ability to be creative, be highly motivated, work independently, and have a background in tissue culture, cell biology, and general molecular and biochemical techniques. Experience with confocal imaging is an advantage. Prior postdoctoral experience is acceptable, but not obligatory.
This position is available effective March 1, 2017, and is a one-year appointment renewable for up three years. All applicants must attend an in-person interview in New York City and should send a CV and cover letter describing their scientific experiences to Dr. Mor at email@example.com.
Neural Engineering and Brain-Machine Interface—January 25, 2017
The Department of Psychiatry at NYU School of Medicine seeks two postdoctoral fellows to participate in a National Institutes of Health-funded research project focused on neural engineering and brain-machine interface. The successful candidate will combine experimental, computational, and engineering techniques to study neural mechanisms of central pain circuits using rodent models. The successful candidate will have the opportunity to interact with a large and growing neuroscience community at NYU, including at the Neuroscience Institute, the Center for Neural Science, the Department of Neuroscience and Physiology, the Department of Psychiatry, and the Department of Anesthesiology, Perioperative Care, and Pain Medicine. Our neuroscience community is also surrounded by other institutions in the greater New York metropolitan area, such as Columbia University Medical Center, Weill Cornell Medical College, The Rockefeller Foundation, and Mount Sinai Medical Group.
For the first postdoctoral position, applicants must have a PhD in biomedical or electrical engineering, statistics, physics, or a related discipline. The desired applicant is expected to be highly motivated and able to work independently as well as cooperatively with other colleagues in all research projects. The ability to learn new techniques and resolve new research challenges is essential. Strong experiences in developing rodent or primate brain-machine interface systems are desired. Strong programming skills in C/C++ or hardware implementation experiences are a plus.
For the second position, applicants must have a PhD in neuroscience or physiology. The successful candidate should be highly motivated and able to work independently as well as cooperatively with other colleagues. The ability to conduct in vivo extracellular neurophysiological recording on rodent experiments is essential. Experience with optogenetics and pain-related research are a plus.
To apply for either position, please email your CV (with a complete list of publications), a cover letter describing research accomplishments and interests, and the names and contact information of two or three references to Zhe (Sage) Chen, PhD at firstname.lastname@example.org with a subject line “postdoc application.”
Mechanisms Involved in Loss of Growth Regulation, Hormone Growth Regulation, and Role of the Ubiquitin Proteasome System in Human Cancer—January 24, 2017
A postdoctoral position is available in the Departments of Medicine and Pathology at NYU School of Medicine to study mechanisms of loss of growth regulation in human cancer, including ubiquitin-mediated degradation of cell cycle proteins and the effects of gonadal steroids on growth regulation of the human endometrium. Our studies use physiological models systems (cells derived directly from human endometrial tissue, primary cultures, co-cultures, and three-dimensional cultures) to compare normal and cancer cells. Using these paradigms, we have found that TGF-β, estrogen, and progesterone converge on the cyclin-dependent kinase inhibitor, p27kip1, as a major target to control normal and malignant endometrial growth (Huang et al., PLoS ONE, 2012). Thus, they can be used as molecular switches to control p27kip1 levels and control cancer growth. We show that p27kip1 is degraded by the E3 ligase complex SCF-Skp2/Cks1 in response to estrogen and have identified small molecule inhibitors that block p27 degradation and regain growth control (Pavlides et al., Endocrinology, 2013).
In addition to further discovering mechanisms of hormonal and TGF-β-regulated growth by the ubiquitin-proteasome system, the successful candidate will be exposed the therapeutic development of these novel Skp2 inhibitors. He or she will work with a top team of scientists ranging from clinicians to imaging specialists and structural and computational biologists as part of this project. Candidates should demonstrate an ability to be creative, be highly motivated, work independently, and have a strong background in molecular and cell biology and tissue culture. Candidates already in the United States with at least two years of postdoctoral experience are preferred. Email your CV and at least three references by email to Leslie I. Gold, PhD, at email@example.com.
Genetic and Tumor Immune Alterations in Lung Tumorigenesis and Pathogenesis—January 23, 2017
A postdoctoral position is available at the Wong Lab at NYU Langone’s Laura and Isaac Perlmutter Cancer Center. Led by Kwok-Kin Wong, MD, PhD, the Wong Lab is a translational oncology laboratory with the goal of improving the outcomes of lung cancer patients. The lab focuses on advancing the understanding of genetic and tumor immune alterations involved in lung tumorigenesis and pathogenesis. The lab has been instrumental in evolving lung cancer into a genetically stratified disease and changing how lung cancer patients are treated. We have pioneered generating and utilizing genetically engineered mouse lung cancer models to validate oncogenic drivers and test novel therapeutics against specific genetic oncogenic drivers. These preclinical models are now being used to lead the next revolution in lung cancer treatment through the combined assessment of genetics and tumor immunology.
The Wong Lab is highly collaborative and works with numerous premier academic investigators and pharmaceutical companies to discovery and delineate the clinical path for novel therapeutic agents. The laboratory publishes in high-impact journals such as Nature, Nature Medicine, and Cancer Cell. Recent postdoctoral fellows trained in the Wong Lab are now investigators at numerous biotech and pharmaceutical companies.
Working with leading academic clinicians and basic scientists as well as scientists from premier biotech and pharmaceutical companies, the successful candidate will perform groundbreaking research to elucidate fundamental understanding of the molecular underpinnings of lung cancer. The successful candidate will do pioneering work on the interplay of genetics, tumor immune infiltrate, and therapeutics in preclinical lung cancer models with the ultimate goal of developing rational treatment hypotheses to be tested in the clinic. In addition, this scientist will have the opportunity to work with industrial (pharma and biotech) partners on the development of next generation lung cancer therapies.
This work will generate an understanding of drug mechanism of actions and development of novel treatments and biomarkers, and identify new targets for novel therapeutics. The successful candidate will also effectively communicate his or her work by writing manuscripts and successfully publishing the results in premier journals.
The successful candidate should have the following qualifications:
- a PhD in cancer biology, immunology, or biological sciences
- experience with molecular biology, genomic analysis, biochemistry, and cell biology
- in vivo pharmacology experience is a plus
- immunology experience is a plus
- demonstrated scientific rigor, scientific excellence, and technical excellence
- the ability to be independent, self-motivated, and innovative
- a strong work ethic
- strong organizational skills
- an outstanding record of publication
- excellent written and oral communication skills
- outstanding interpersonal skills
- the ability to work productively and constructively in a team environment
- the ability to excel in a goal-oriented, multifaceted, and fast-moving team environment
If you are interested in applying, please email project manager Christina Almonte at firstname.lastname@example.org.
Vascular Biology and Lipid Metabolism—January 18, 2017
There are several postdoctoral fellowship positions available in NYU School of Medicine’s Leon H. Charney Division of Cardiology due to the awarding of a National Institutes of Health Program Project grant focusing on macrophage dysfunction in obesity, diabetes, and atherosclerosis. The successful candidate will investigate the mechanisms affecting atherosclerotic plaque or adipose tissue macrophage content and inflammatory states in diabetes or diet-induced obesity. This multiproject interdisciplinary program will expose fellows to a wide scope of translational disease-related science and the opportunity to train with distinguished faculty members in the areas of cardiology, endocrinology, and immunology/inflammation.
We are seeking exceptionally well-qualified applicants to work on the program. Candidates with a recent PhD, MD/PhD, or MD with a strong research background in relevant areas are encouraged to apply directly by emailing program coordinator Julia Levine at email@example.com. Applicants should include a CV, brief statement of research background, and three letters of reference or names and addresses of referees.
Mechanisms and Treatment of Anxiety, Trauma, and Grief-Related Disorders—January 13, 2017
Two postdoctoral psychiatry fellowships are available for July 2017 at NYU Langone’s Anxiety and Complicated Grief Program led by Naomi Simon, MD, MSc. The Anxiety and Complicated Grief Program is a new clinical research program focused on improving our understanding and treatment of anxiety and fear-related disorders and complicated grief through clinical investigation and treatment studies. The program intends to leverage the exponential growth in real-time advances in genetics, neurobiology, molecular biology, and psychology to better understand key factors that lead to the development and persistence of anxiety and grief disorders as well as their optimal treatment.
The fellowship is designed to provide comprehensive training in research investigation and clinical care in anxiety, grief, and fear-based disorders including complicated grief, panic disorder, social anxiety disorder, generalized anxiety disorder, and post-traumatic stress disorder. Ongoing studies at various stages of recruitment and data analysis include clinical trials of pharmacotherapy, cognitive behavioral therapy, and yoga, as well as blood-based biomarker cross diagnostic research. The lab also applies psychophysiological assessments and fear-conditioning paradigms, emotion perception experiments, real-time monitoring, and sleep-related studies, and collaborates with neuroimaging laboratories. The postdoctoral fellow will have the exciting opportunity to assist in the development of this new program and will receive close mentorship and support as he or she continues to develop his or her own professional career in psychiatry and clinical research.
Applicants must have an MD and have completed a residency in psychiatry by July 2017 or have a PhD and completed an internship in clinical psychology by July 2017. Competitive applicants will have prior experience in relevant clinical care and/or research; a background in related psychology, neuroscience, and/or biological studies; and demonstrated interest in this line of research as exemplified by academic presentations and/or peer-review publications. All those motivated to pursue a career in clinical research to investigate the phenomenology, mechanisms, and treatment of anxiety, fear, and/or grief-related conditions will be considered for the position and are encouraged to apply.
Cardiovascular Biology—January 12, 2017
Positions are available for exceptionally talented MD and/or PhD candidates seeking advanced training in cardiovascular biology. Selected candidates will be eligible for appointment to our National Institutes of Health-funded T32 Training Program. Our program focuses on cardiovascular electrophysiology and arrhythmia mechanisms, and includes studies of conduction system development, stem cell biology, small and large animal models of disease, and genomics/epigenetics/systems biology. The environment for cardiovascular investigation is exceptional, with numerous highly interactive faculty members collaborating on studies that range from basic and translational to clinical investigation.
The ideal candidate will have extensive experience in molecular and cellular biology, tissue culture, and murine models. Candidates with expertise in stem cell biology, cellular electrophysiology, and/or in vivo and ex vivo physiology are particularly encouraged to apply. Interested candidates are invited to send a CV, brief statement of research interest, and names of three references or letter of references to Glenn I. Fishman, MD, director, Leon H. Charney Division of Cardiology, at firstname.lastname@example.org.